Kane Biotech, Inc. (KNE.V)
0.025
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Kane Biotech Debt to Equity Ratio : -1.352 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.352 |
| September 30, 2025 | -2.896 |
| June 30, 2025 | -11.04 |
| March 31, 2025 | -1.821 |
| December 31, 2024 | -1.335 |
| September 30, 2024 | -3.314 |
| June 30, 2024 | -3.307 |
| March 31, 2024 | -0.7839 |
| September 30, 2023 | -0.9992 |
| June 30, 2023 | -0.9476 |
| March 31, 2023 | -1.011 |
| December 31, 2022 | -1.046 |
| September 30, 2022 | -1.143 |
| June 30, 2022 | -1.399 |
| March 31, 2022 | -1.006 |
| December 31, 2021 | -1.213 |
| September 30, 2021 | -1.684 |
| June 30, 2021 | -1.685 |
| March 31, 2021 | -1.026 |
| December 31, 2020 | -1.510 |
| September 30, 2020 | -1.037 |
| June 30, 2020 | 3.561 |
| March 31, 2020 | 0.5202 |
| December 31, 2019 | 0.2029 |
| September 30, 2019 | -2.155 |
| Date | Value |
|---|---|
| June 30, 2019 | 29.87 |
| March 31, 2019 | -0.9507 |
| December 31, 2018 | -0.5077 |
| September 30, 2018 | 1.879 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 2.068 |
| March 31, 2017 | 0.4672 |
| December 31, 2016 | 0.3871 |
| September 30, 2016 | 0.2564 |
| June 30, 2016 | 0.1911 |
| March 31, 2016 | 2.953 |
| December 31, 2015 | 1.041 |
| September 30, 2015 | 1.030 |
| June 30, 2015 | 0.8325 |
| March 31, 2015 | 0.5274 |
| December 31, 2014 | 0.3648 |
| September 30, 2014 | 0.8489 |
| June 30, 2014 | 0.5131 |
| March 31, 2014 | 0.3208 |
| December 31, 2013 | 0.322 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Quest PharmaTech, Inc. | 0.0378 |
| BriaCell Therapeutics Corp. | 0.00 |
| Vaxil Bio Ltd. | 0.00 |
| Waverley Pharma, Inc. | -1.299 |
| Goldcoast Resource Corp. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.811M |
| Total Liabilities (Quarterly) | 3.229M |
| Shareholders Equity (Quarterly) | -1.418M |
| Current Ratio | 0.4535 |
| Net Debt Paydown Yield | 1.34% |